Silexion Therapeutics Reports Positive Preclinical Data Demonstrating SIL204’s Reach and Activity in Major Pancreatic Cancer Metastatic Sites Following Systemic Administration
Globenewswire· 2025-09-11 19:00
New Positive Preclinical Data Shows Succesful Drug Distribution to Liver, Peritoneum, and Lung with Measurable Reductions in Tumor Burden at Clinically Relevant Doses Results Provide Further Validation of the Systemic Component of a Dual-Route Administration Strategy Enabeling Potential Targeting of Both Primary Tumors and Metastatic Disease Silexion Remains on Track for Phase 2/3 Trial Initiation in H1 2026 Following Planned Q4 2025 and Q1 2026 Regulatory Submissions GRAND CAYMAN, Cayman Islands, Sept. 1 ...
OR Royalties Announces More Positive Developments on Select Assets
Globenewswire· 2025-09-11 19:00
MONTRÉAL, Sept. 11, 2025 (GLOBE NEWSWIRE) -- OR Royalties Inc. (“OR Royalties” or the “Company”) (OR: TSX & NYSE) is pleased to provide the following select asset updates. Amounts presented are in United States dollars, except where otherwise noted. Jason Attew, President & CEO of OR Royalties commented: “Today’s update illustrates the continued momentum across OR Royalties’ portfolio of development and exploration assets. Positive advancements at Cascabel, Cariboo, Marimaca MOD, Spring Valley, Dalgaranga a ...
Enovix Announces Pricing of $300.0 Million Offering of 4.75% Convertible Senior Notes Due 2030
Globenewswire· 2025-09-11 19:00
FREMONT, Calif., Sept. 11, 2025 (GLOBE NEWSWIRE) -- Enovix Corporation (Nasdaq: ENVX, ENVXW) (the “Company” or “Enovix”), a leader in advanced silicon battery technology, today announced the pricing of $300.0 million aggregate principal amount of 4.75% Convertible Senior Notes due 2030 (the “Notes”) in a private placement (the “Offering”) to persons reasonably believed to be qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended (the “Securities Act”). Enovix also ...
The Lovesac Company Reports Second Quarter Fiscal 2026 Financial Results
Globenewswire· 2025-09-11 19:00
Q2 FY26 Net Sales Increased 2.5% to $160.5 Million vs. Q2 FY25STAMFORD, Conn., Sept. 11, 2025 (GLOBE NEWSWIRE) -- The Lovesac Company (Nasdaq: LOVE) (“Lovesac” or the “Company”), the Designed for Life home and technology brand best known for its Sactionals, The World's Most Adaptable Couch, today announced financial results for the second quarter of fiscal 2026, which ended August 3, 2025. Shawn Nelson, Chief Executive Officer, stated, “We're pleased to have delivered another quarter of market share gains u ...
Magna Names Philip D. Fracassa Chief Financial Officer
Globenewswire· 2025-09-11 18:45
Philip D. Fracassa Philip D. Fracassa joins Magna as Executive Vice-President and Chief Financial Officer, succeeding Patrick McCann Patrick McCann to step down after more than 26 years with Magna, including as CFO since 2022Philip Fracassa joins Magna as CFO effective immediately after 20 years at The Timken Company (NYSE: TKR), where he held the CFO role for over a decadeMagna looks forward to continuing to execute on its long-term strategy, including by building on its strong first-half performance ...
K92 Mining Announces Major Regional Exploration Update: Significant Expansion of Arakompa Deposit, Discovery of Porphyry-Style Mineralization from Arakompa Southernmost Step-Out, and Substantial 3.5 km by 3.5 km New Mineralized System Discovered at Wera
Globenewswire· 2025-09-11 18:30
VANCOUVER, British Columbia, Sept. 11, 2025 (GLOBE NEWSWIRE) -- K92 Mining Inc. (“K92” or the “Company”) (TSX: KNT; OTCQX: KNTNF) is pleased to announce its fifth set of drilling results consisting of 24 holes for total results of 67 holes released to date from its maiden surface diamond drill program at Arakompa, located approximately 4.5 km from the Kainantu Gold Mine Process Plant in Papua New Guinea. Additionally, K92 is pleased to report initial results from its maiden greenfields exploration program a ...
First Patient Enrolled in DUBSTENT DIABETES Trial: Targeting Improved PCI Outcomes for Diabetic Patients
Globenewswire· 2025-09-11 18:30
The Trial Evaluates a Combined PCI Approach Using Drug-Coated Balloons and Drug-Eluting StentsWAYNE, Pa., Sept. 11, 2025 (GLOBE NEWSWIRE) -- Teleflex Incorporated (NYSE:TFX), a leading global provider of medical technologies, today announced the enrollment of the first patient in the DUBSTENT DIABETES trial. The randomized, investigator-initiated clinical study will evaluate a dual-device strategy for percutaneous coronary intervention (PCI) in patients with diabetes mellitus. The DUBSTENT DIABETES trial wi ...
Amesite Reports 63% Revenue Growth from NurseMagic™ Enterprise; Announces Launch of AI-Powered Government Form-Fill Automation to Reduce Reporting Burden
Globenewswire· 2025-09-11 18:30
DETROIT, Sept. 11, 2025 (GLOBE NEWSWIRE) -- Amesite Inc. (NASDAQ: AMST), a leading developer of AI-powered enterprise solutions, today announced 63% revenue growth for its NurseMagic™ platform following the launch of its census-based Enterprise subscription model on July 14, 2025. Enterprise sales have now surpassed B2C sales, reflecting rising demand from post-acute care providers seeking scalable, compliant technology designed to deliver full reimbursement rates. Amesite also announces the launch of its A ...
UTime Limited Announces Board Changes and Confirms Corporate Governance Stability
Globenewswire· 2025-09-11 18:02
7th Floor, Building 5A Shenzhen Software Industry Base, Nanshan District Shenzhen, People’s Republic of China 518061 Shenzhen, China, Sept. 11, 2025 (GLOBE NEWSWIRE) -- UTime Limited (Nasdaq: WTO, the “Company”) today confirms that recent changes to its Board of Directors have been completed in accordance with the Company's Articles of Association and relevant procedures, and have been publicly announced. The Company reiterates that its Board structure remains intact, governance mechanisms are functioning n ...
Hooker Furnishings Reports Fiscal 2026 Second Quarter Results
Globenewswire· 2025-09-11 18:00
Company reaffirms dividend, maintains profitability focus, and positions for growthMARTINSVILLE, Va., Sept. 11, 2025 (GLOBE NEWSWIRE) -- Hooker Furnishings Corporation (NASDAQ-GS: HOFT) (“Hooker” or the “Company”), a global leader in home furnishings, today reported operating results for its fiscal 2026 second quarter ended August 3, 2025. Executive Commentary “Hooker Furnishings is taking decisive steps to return the business to profitability. Our cost-reduction initiatives and focus on growth initiatives ...